Michael Ryskin
Stock Analyst at B of A Securities
(0.6)
# 2443
Out of 5,337 analysts
43
Total ratings
45.45%
Success rate
-3.49%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
MRVI Maravai LifeSciences | Maintains: Buy | 9 8 | 2 | 300% | 3 | Mar 3, 2025 | |
TEM Tempus AI | Maintains: Neutral | 54 60 | 64.75 | -7.34% | 4 | Mar 3, 2025 | |
IDXX IDEXX Laboratories | Maintains: Neutral | 475 535 | 509.55 | 4.99% | 2 | Feb 4, 2025 | |
ALGN Align Tech | Maintains: Underperform | 200 206 | 187.78 | 9.7% | 6 | Dec 13, 2024 | |
GH Guardant Health | Maintains: Strong Buy | 28 40 | 40.78 | -1.91% | 1 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 10 10 | 5.85 | 62.39% | 1 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 11 9 | n/a | n/a | 2 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 27 24 | 11.7 | 105.13% | 2 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 27 24 | 12.85 | 86.77% | 2 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 25 | n/a | n/a | 2 | Jun 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 225 180 | 154.83 | 16.26% | 7 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 90 | n/a | n/a | 3 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 80 52 | 23.9 | 117.57% | 2 | Nov 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 17 10 | 2.92 | 242.47% | 2 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 10 7 | n/a | n/a | 2 | May 14, 2020 |